We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+10.51%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$104M
AUM Growth
+$8.55M
(+9%)
Cap. Flow
+$7.51M
Cap. Flow
% of AUM
7.22%
Top 10 Holdings %
Top 10 Hldgs %
35.65%
Holding
124
New
22
Increased
30
Reduced
40
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEAR
TearLab Corporation
TEAR
|
+$1.85M |
| 2 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
+$1.31M |
| 3 |
Target
TGT
|
+$1.13M |
| 4 |
Ring Energy
REI
|
+$1.03M |
| 5 |
Tactile Systems Technology
TCMD
|
+$979K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axogen
AXGN
|
+$1.07M |
| 2 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$1.05M |
| 3 |
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
|
+$1.05M |
| 4 |
Cencora
COR
|
+$976K |
| 5 |
CryoPort
CYRX
|
+$602K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.08% |
| 2 | Technology | 10.55% |
| 3 | Industrials | 9.42% |
| 4 | Financials | 4.89% |
| 5 | Consumer Staples | 3.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Target
TGT
$63.7B
| $1.22M | 1.17% |
+18,700
| New | +$1.13M |
|
27
Apyx Medical
APYX
$164M
| $1.21M | 1.17% |
466,300
-157,385
| -25% | -$491K |
|
|
28
Ring Energy
REI
$297M
| $1.21M | 1.16% |
86,725
+76,725
| +767% | +$1.03M |
|
|
TEUM
29
DELISTED
Pareteum Corporation
TEUM
| $1.15M | 1.1% |
553,479
+503,479
| +1,007% | +$567K |
|
30
Stanley Black & Decker
SWK
$14.6B
| $1.11M | 1.07% |
6,550
| – | – |
|
31
Deluxe
DLX
$1.22B
| $1.1M | 1.06% |
14,350
+1,950
| +16% | +$141K |
|
|
PFIE
32
DELISTED
Profire Energy, Inc
PFIE
| $1.09M | 1.05% |
569,481
+43,000
| +8% | +$80.5K |
|
33
Altria Group
MO
$122B
| $1.08M | 1.04% |
15,200
-500
| -3% | -$33.5K |
|
|
34
CryoPort
CYRX
$764M
| $1.08M | 1.04% |
126,250
-76,740
| -38% | -$602K |
|
35
H.B. Fuller
FUL
$3.04B
| $1.01M | 0.97% |
18,700
+350
| +2% | +$19.5K |
|
|
CTLP
36
DELISTED
Cantaloupe
CTLP
| $1M | 0.96% |
102,850
-8,000
| -7% | -$61.4K |
|
37
Pentair
PNR
$10.2B
| $985K | 0.95% |
20,772
-297
| -1% | -$13.9K |
|
|
38
Tactile Systems Technology
TCMD
$626M
| $978K | 0.94% |
+33,750
| New | +$979K |
|
39
CVS Health
CVS
$137B
| $964K | 0.93% |
13,300
-900
| -6% | -$65.4K |
|
40
Expeditors International
EXPD
$22.4B
| $961K | 0.92% |
14,850
+1,000
| +7% | +$61.3K |
|
41
Blackstone
BX
$106B
| $949K | 0.91% |
29,650
+1,500
| +5% | +$48.8K |
|
|
VG
42
DELISTED
Vonage Holdings Corporation
VG
| $876K | 0.84% |
86,125
+16,675
| +24% | +$152K |
|
43
Bank of America
BAC
$436B
| $850K | 0.82% |
+28,800
| New | +$794K |
|
|
ZIXI
44
DELISTED
Zix Corporation
ZIXI
| $801K | 0.77% |
182,979
-70,600
| -28% | -$332K |
|
45
AllianceBernstein
AB
$3.54B
| $798K | 0.77% |
+31,850
| New | +$805K |
|
|
ENSV
46
DELISTED
Enservco Corp.
ENSV
| $782K | 0.75% |
80,945
| – | – |
|
47
Standard BioTools
LAB
$303M
| $781K | 0.75% |
+132,650
| New | +$726K |
|
48
AngioDynamics
ANGO
$565M
| $779K | 0.75% |
46,850
-1,800
| -4% | -$30.7K |
|
49
ePlus
PLUS
$2.33B
| $752K | 0.72% |
20,000
| – | – |
|
|
CGRN
50
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $744K | 0.72% |
+96,574
| New | +$860K |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
CAG
FTEA
WT
Perkins Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Perkins Capital Management held 124 positions worth $104M, up 9% from $95.4M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Perkins Capital Management deployed $7.51M of net new capital in Q4 2017, opening 22 new positions and adding to 30 existing holdings. Its largest new stake was Flexion Therapeutics, Inc.: 53,500 shares worth $1.34M.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 64% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Axogen, an estimated $1.07M trimmed.
- Perkins Capital Management's largest Q4 2017 buy was Flexion Therapeutics, Inc.: 53,500 shares worth $1.34M.
- Perkins Capital Management added most to TearLab Corporation in Q4 2017, an estimated $1.85M increase.
- Perkins Capital Management's biggest Q4 2017 reduction was Axogen, cutting an estimated $1.07M.
- Perkins Capital Management fully exited Entellus Medical, Inc. Common Stock in Q4 2017, selling an estimated $1.05M.
- Perkins Capital Management's ten largest holdings make up 36% of its $104M portfolio in Q4 2017.
- Perkins Capital Management opened 22 new positions and closed 12 in Q4 2017.
- Perkins Capital Management's portfolio value rose 9% quarter-over-quarter to $104M.
Based on Perkins Capital Management's 13F filing for Q4 2017, filed 26 Jan 2018.